Clinical Trial Update: Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing BCD-057 to Humira in moderate-to-severe plaque psoriasis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• BCD-057
• Humira (adalimumab)

Snippet

Sponsor: Biocad | Conditions: Psoriasis | Phase 3 | Status: COMPLETED